TP53 and cancer: The mortaparib [IUPAC Name: 5-[1-(4-methoxyphenyl)(1,2,3,4-tetra azol-5-yl)]-4-phenylpyrimidine-2-ylamine] chemical structure, shown in Figure 3 [78], was isolated in a cancer cell-based screening assay with double readouts: (i) shift of Mortalin staining pattern from perinuclear to pancytoplasmic and (ii) nuclear translocation of p53 [78].